Bio-Connect

Goat anti-ADRB1

EB07133
Everest Biotech
ApplicationsImmunoFluorescence, ELISA, ImmunoHistoChemistry
Product group Antibodies
TargetADRB1
100 ug
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Everest Biotech
  • Product Name
    Goat anti-ADRB1 Antibody
  • Delivery Days Customer
    5
  • Application Supplier Note
    Immunofluorescence: Strong expression of the protein seen in the plama membrane and cytoplasm of HeLa cells. Recommended concentration: 10microg/ml.
  • Applications
    ImmunoFluorescence, ELISA, ImmunoHistoChemistry
  • Applications Supplier
    Pep-ELISA, IHC, IF
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.5 mg/ml
  • Gene ID153
  • Target name
    ADRB1
  • Target description
    adrenoceptor beta 1
  • Target synonyms
    ADRB1R, B1AR, BETA1AR, FNSS2, RHR, beta-1 adrenergic receptor, adrenergic, beta-1-, receptor, beta-1 adrenoceptor, beta-1 adrenoreceptor
  • Host
    Goat
  • Scientific Description
    RefSeq number(s): NP_000675.1. Purification: Antigen affinity purified. Names and symbols: ADRB1; adrenergic, beta-1-, receptor; ADRB1R; B1AR; BETA1AR; RHR; beta-1-adrenergic receptor
  • Reactivity Supplier
    Human, Mouse, Rat, Dog
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203

References

  • Wallukat G, Prüss H, Müller J, et al. Functional autoantibodies in patients with different forms of dementia. PLoS One. 2018,13(3):e0192778. doi: 10.1371/journal.pone.0192778
    Read this paper
  • Wenzel K, Schulze-Rothe S, Müller J, et al. Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology. PLoS One. 2018,13(2):e0192615. doi: 10.1371/journal.pone.0192615
    Read this paper
  • Wenzel K, Schulze-Rothe S, Haberland A, et al. Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathy. Heliyon. 2017,3(7):e00362. doi: 10.1016/j.heliyon.2017.e00362
    Read this paper
  • Wallukat G, Haberland A, Berg S, et al. The first aptamer-apheresis column specifically for clearing blood of β1-receptor autoantibodies. Circ J. 2012,76(10):2449-55.
    Read this paper
  • Haberland A, Wallukat G, Dahmen C, et al. Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies. Circ Res. 2011,109(9):986-92. doi: 10.1161/CIRCRESAHA.111.253849
    Read this paper
  • Wallukat G, Muñoz Saravia SG, Haberland A, et al. Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients. J Am Coll Cardiol. 2010,55(5):463-8. doi: 10.1016/j.jacc.2009.06.064
    Read this paper